Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
MDCX Quote, Financials, Valuation and Earnings
Last price:
$3.23
Seasonality move
:
-0.57%
Day range:
$2.93 - $3.15
52-week range:
$1.80 - $12.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
22.48x
Volume:
376.2K
Avg. volume:
445.6K
1-year change:
-57.2%
Market cap:
$48.3M
Revenue:
--
EPS (TTM):
-$1.41
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $1.2M | $646.4K | $193.6K | $3.5M | |
| Selling, General & Admin | -- | $258K | $332K | $2.5M | $7.7M | |
| Other Inc / (Exp) | -- | $77K | $388.3K | -$2.1M | $238.5K | |
| Operating Expenses | -- | $1.4M | $978.4K | $2.7M | $11.2M | |
| Operating Income | -- | -$1.4M | -$978.4K | -$2.7M | -$11.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$2.1M | -$1.7M | -$5.3M | -$11.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$2.1M | -$1.7M | -$5.3M | -$11.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$2.1M | -$1.7M | -$5.3M | -$11.2M | |
| Basic EPS (Cont. Ops) | -- | -$0.26 | -$0.88 | -$1.53 | -$1.16 | |
| Diluted EPS (Cont. Ops) | -- | -$0.26 | -$0.88 | -$1.53 | -$1.16 | |
| Weighted Average Basic Share | -- | $8M | $1.9M | $3.5M | $9.6M | |
| Weighted Average Diluted Share | -- | $8M | $8M | $3.5M | $9.6M | |
| EBITDA | -- | -$1.9M | -$1.2M | -$2.7M | -$10.3M | |
| EBIT | -- | -$1.9M | -$1.2M | -$2.7M | -$10.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$1.4M | -$978.4K | -$2.7M | -$11.2M | |
| Operating Income (Adjusted) | -- | -$1.9M | -$1.2M | -$2.7M | -$10.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $181.6K | $69.1K | $321.4K | $2M | |
| Selling, General & Admin | -- | $86.2K | $333.4K | $1.4M | $3.1M | |
| Other Inc / (Exp) | -- | $57.7K | $253.2K | -- | -- | |
| Operating Expenses | -- | $267.8K | $402.5K | $1.7M | $5.1M | |
| Operating Income | -- | -$267.8K | -$402.5K | -$1.7M | -$5.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$438.3K | -$483.9K | -$1.7M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$483.3K | -$483.9K | -$1.7M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$438.3K | -$483.9K | -$1.7M | -$5.1M | |
| Basic EPS (Cont. Ops) | -- | -$0.22 | -$0.06 | -$0.21 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -- | -$0.22 | -$0.06 | -$0.21 | -$0.42 | |
| Weighted Average Basic Share | -- | $2M | $8M | $8.1M | $12.2M | |
| Weighted Average Diluted Share | -- | $2M | $8M | $8.1M | $12.2M | |
| EBITDA | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| EBIT | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$267.8K | -$402.5K | -$1.7M | -$5.1M | |
| Operating Income (Adjusted) | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $533.9K | $445.8K | $5.2M | |
| Selling, General & Admin | -- | -- | $579.3K | $3.5M | $9.3M | |
| Other Inc / (Exp) | -- | $57.7K | $583.8K | -$2M | -- | |
| Operating Expenses | -- | -- | $1.1M | $4M | $14.5M | |
| Operating Income | -- | -- | -$1.1M | -$4M | -$14.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$1.7M | -$6.5M | -$14.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$1.7M | -$6.5M | -$14.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$1.7M | -$6.5M | -$14.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.48 | -$1.91 | -$1.41 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.48 | -$1.91 | -$1.41 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$1.1M | -$4.1M | -$13.5M | |
| EBIT | -- | -- | -$1.1M | -$4.1M | -$13.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$1.1M | -$4M | -$14.5M | |
| Operating Income (Adjusted) | -- | -- | -$1.1M | -$4.1M | -$13.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $181.6K | $69.1K | $321.4K | $2M | |
| Selling, General & Admin | -- | $86.2K | $333.4K | $1.4M | $3.1M | |
| Other Inc / (Exp) | -- | $57.7K | $253.2K | -- | -- | |
| Operating Expenses | -- | $267.8K | $402.5K | $1.7M | $5.1M | |
| Operating Income | -- | -$267.8K | -$402.5K | -$1.7M | -$5.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$438.3K | -$483.9K | -$1.7M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$483.3K | -$483.9K | -$1.7M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$438.3K | -$483.9K | -$1.7M | -$5.1M | |
| Basic EPS (Cont. Ops) | -- | -$0.22 | -$0.06 | -$0.21 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -- | -$0.22 | -$0.06 | -$0.21 | -$0.42 | |
| Weighted Average Basic Share | -- | $2M | $8M | $8.1M | $12.2M | |
| Weighted Average Diluted Share | -- | $2M | $8M | $8.1M | $12.2M | |
| EBITDA | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| EBIT | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$267.8K | -$402.5K | -$1.7M | -$5.1M | |
| Operating Income (Adjusted) | -- | -$354K | -$293.2K | -$1.7M | -$5.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $78.5K | $267.7K | $1.7M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $15K | $173.7K | $1.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $78.5K | $282.7K | $1.9M | $5.4M | |
| Property Plant And Equipment | -- | -- | -- | -- | $268.6K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $78.5K | $282.7K | $1.9M | $5.6M | |
| Accounts Payable | -- | -- | -- | $210.8K | $1.3M | |
| Accrued Expenses | -- | -- | -- | $377.1K | $621.9K | |
| Current Portion Of Long-Term Debt | -- | $667.9K | $1.4M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $116.3K | |
| Other Current Liabilities | -- | $9.8M | $10.8M | -- | -- | |
| Total Current Liabilities | -- | $10.6M | $12.5M | $781.6K | $2.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $10.6M | $12.5M | $781.6K | $2.5M | |
| Common Stock | -- | $194.5K | $194.5K | $18.8M | $30.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -$10.5M | -$12.2M | $1.1M | $3.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$10.5M | -$12.2M | $1.1M | $3.1M | |
| Total Liabilities and Equity | -- | $78.5K | $282.7K | $1.9M | $5.6M | |
| Cash and Short Terms | -- | $78.5K | $267.7K | $1.7M | $4.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $28.1K | $542.4K | $4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $7.8K | $112.1K | $1.1M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $35.9K | $654.5K | $5.1M | |
| Property Plant And Equipment | -- | -- | -- | $330.8K | $245.1K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $35.9K | $985.2K | $5.7M | |
| Accounts Payable | -- | -- | -- | -- | $2M | |
| Accrued Expenses | -- | -- | -- | -- | $972.3K | |
| Current Portion Of Long-Term Debt | -- | -- | $1.6M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $71.1K | $120.3K | |
| Other Current Liabilities | -- | -- | $10.7M | -- | -- | |
| Total Current Liabilities | -- | -- | $12.7M | $1.3M | $3.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $12.7M | $1.6M | $3.5M | |
| Common Stock | -- | -- | $194.5K | $19.8M | $32.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -$12.7M | -$610.3K | $2.1M | |
| Total Liabilities and Equity | -- | -- | $35.9K | $985.2K | $5.7M | |
| Cash and Short Terms | -- | -- | $28.1K | $542.4K | $4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$2.1M | -$1.7M | -$5.3M | -$11.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $98.6K | $713.1K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$1.4M | -$1.1M | -$4.2M | -$10.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $882.4K | $1.2M | $500K | $5.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $5.1M | -- | |
| Cash From Financing | -- | $882.4K | $1.2M | $5.6M | $12.7M | |
| Beginning Cash (CF) | -- | $644.2K | $78.5K | $267.7K | $1.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$565.7K | $189.1K | $1.5M | $2.4M | |
| Ending Cash (CF) | -- | $78.5K | $267.7K | $1.7M | $4.2M | |
| Levered Free Cash Flow | -- | -$1.4M | -$1.1M | -$4.2M | -$10.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$483.3K | -$483.9K | -$1.7M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $36K | $112.3K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$273.6K | -$239.6K | -$1.2M | -$3.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $604.9K | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$25K | |
| Cash From Financing | -- | $604.9K | -- | -- | $3.8M | |
| Beginning Cash (CF) | -- | $78.5K | $267.7K | $1.7M | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $331.4K | -$239.6K | -$1.2M | -$181.9K | |
| Ending Cash (CF) | -- | $409.9K | $28.1K | $542.4K | $4M | |
| Levered Free Cash Flow | -- | -$273.6K | -$239.6K | -$1.2M | -$3.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$1.7M | -$6.5M | -$14.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $134.5K | $789.4K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$1M | -$5.1M | -$13M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $5.6M | $16.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$381.8K | $514.3K | $3.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$1M | -$5.1M | -$13M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$483.3K | -$483.9K | -$1.7M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $36K | $112.3K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$273.6K | -$239.6K | -$1.2M | -$3.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $604.9K | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$25K | |
| Cash From Financing | -- | $604.9K | -- | -- | $3.8M | |
| Beginning Cash (CF) | -- | $78.5K | $267.7K | $1.7M | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $331.4K | -$239.6K | -$1.2M | -$181.9K | |
| Ending Cash (CF) | -- | $409.9K | $28.1K | $542.4K | $4M | |
| Levered Free Cash Flow | -- | -$273.6K | -$239.6K | -$1.2M | -$3.9M | |
Get MDCX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDCX
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
22.48x
1.80x
Price / LTM sales
--
1.65x
Growth Metrics
MDCX
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$0.27
-$0.20
Profitability
MDCX
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
29
Estimated Next Earnings Date
Aug
11
Balance Sheet
MDCX
Sector
Total cash
$4M
$35.5M
Short term investments
--
$29.7M
Total assets
$5.6M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
